0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lisinopril Tablets Market Research Report 2023
Published Date: May 2023
|
Report Code: QYRE-Auto-4W11860
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Lisinopril Tablets Market Research Report 2022
BUY CHAPTERS

Global Lisinopril Tablets Market Research Report 2023

Code: QYRE-Auto-4W11860
Report
May 2023
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lisinopril Tablets Market

The global Lisinopril Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lisinopril Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lisinopril Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Lisinopril Tablets include Shanghai Sine WANXIANG Pharmaceuticals, ZHONGFU Pharmaceutical, Ningbo Menovo TianKang Pharmaceutical, Shanghai Great Wall Pharmaceutical, Sinopharm Shantou Jinshi Pharmaceutical, Jiangsu Huanghe Medical, Yichang HEC Changjiang Pharmaceutical, Hebei Wansui Pharmaceutical and Jincheng Haisi Pharmaceutical, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lisinopril Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lisinopril Tablets.
The Lisinopril Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lisinopril Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lisinopril Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Lisinopril Tablets Market Report

Report Metric Details
Report Name Lisinopril Tablets Market
Segment by Type
  • 5mg/Tablet
  • 10mg/Tablet
  • 20mg/Tablet
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shanghai Sine WANXIANG Pharmaceuticals, ZHONGFU Pharmaceutical, Ningbo Menovo TianKang Pharmaceutical, Shanghai Great Wall Pharmaceutical, Sinopharm Shantou Jinshi Pharmaceutical, Jiangsu Huanghe Medical, Yichang HEC Changjiang Pharmaceutical, Hebei Wansui Pharmaceutical, Jincheng Haisi Pharmaceutical, Jiangsu Kanion Pharmaceutical, Zhejiang Huahai Pharmaceutical, Facmed Pharmaceuticals, Crescent, Bristol, Actavis, Healing Pharma, TAJ Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lisinopril Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lisinopril Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
1 Lisinopril Tablets Market Overview
1.1 Product Overview and Scope of Lisinopril Tablets
1.2 Lisinopril Tablets Segment by Type
1.2.1 Global Lisinopril Tablets Market Value Comparison by Type (2023-2029)
1.2.2 5mg/Tablet
1.2.3 10mg/Tablet
1.2.4 20mg/Tablet
1.3 Lisinopril Tablets Segment by Application
1.3.1 Global Lisinopril Tablets Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Lisinopril Tablets Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Tablets Revenue 2018-2029
1.4.2 Global Lisinopril Tablets Sales 2018-2029
1.4.3 Global Lisinopril Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lisinopril Tablets Market Competition by Manufacturers
2.1 Global Lisinopril Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Lisinopril Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Lisinopril Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Lisinopril Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Lisinopril Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lisinopril Tablets, Product Type & Application
2.7 Lisinopril Tablets Market Competitive Situation and Trends
2.7.1 Lisinopril Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lisinopril Tablets Players Market Share by Revenue
2.7.3 Global Lisinopril Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lisinopril Tablets Retrospective Market Scenario by Region
3.1 Global Lisinopril Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lisinopril Tablets Global Lisinopril Tablets Sales by Region: 2018-2029
3.2.1 Global Lisinopril Tablets Sales by Region: 2018-2023
3.2.2 Global Lisinopril Tablets Sales by Region: 2024-2029
3.3 Global Lisinopril Tablets Global Lisinopril Tablets Revenue by Region: 2018-2029
3.3.1 Global Lisinopril Tablets Revenue by Region: 2018-2023
3.3.2 Global Lisinopril Tablets Revenue by Region: 2024-2029
3.4 North America Lisinopril Tablets Market Facts & Figures by Country
3.4.1 North America Lisinopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lisinopril Tablets Sales by Country (2018-2029)
3.4.3 North America Lisinopril Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lisinopril Tablets Market Facts & Figures by Country
3.5.1 Europe Lisinopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lisinopril Tablets Sales by Country (2018-2029)
3.5.3 Europe Lisinopril Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lisinopril Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Lisinopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lisinopril Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Lisinopril Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lisinopril Tablets Market Facts & Figures by Country
3.7.1 Latin America Lisinopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lisinopril Tablets Sales by Country (2018-2029)
3.7.3 Latin America Lisinopril Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lisinopril Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Lisinopril Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lisinopril Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lisinopril Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lisinopril Tablets Sales by Type (2018-2029)
4.1.1 Global Lisinopril Tablets Sales by Type (2018-2023)
4.1.2 Global Lisinopril Tablets Sales by Type (2024-2029)
4.1.3 Global Lisinopril Tablets Sales Market Share by Type (2018-2029)
4.2 Global Lisinopril Tablets Revenue by Type (2018-2029)
4.2.1 Global Lisinopril Tablets Revenue by Type (2018-2023)
4.2.2 Global Lisinopril Tablets Revenue by Type (2024-2029)
4.2.3 Global Lisinopril Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Lisinopril Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lisinopril Tablets Sales by Application (2018-2029)
5.1.1 Global Lisinopril Tablets Sales by Application (2018-2023)
5.1.2 Global Lisinopril Tablets Sales by Application (2024-2029)
5.1.3 Global Lisinopril Tablets Sales Market Share by Application (2018-2029)
5.2 Global Lisinopril Tablets Revenue by Application (2018-2029)
5.2.1 Global Lisinopril Tablets Revenue by Application (2018-2023)
5.2.2 Global Lisinopril Tablets Revenue by Application (2024-2029)
5.2.3 Global Lisinopril Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Lisinopril Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shanghai Sine WANXIANG Pharmaceuticals
6.1.1 Shanghai Sine WANXIANG Pharmaceuticals Corporation Information
6.1.2 Shanghai Sine WANXIANG Pharmaceuticals Description and Business Overview
6.1.3 Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Product Portfolio
6.1.5 Shanghai Sine WANXIANG Pharmaceuticals Recent Developments/Updates
6.2 ZHONGFU Pharmaceutical
6.2.1 ZHONGFU Pharmaceutical Corporation Information
6.2.2 ZHONGFU Pharmaceutical Description and Business Overview
6.2.3 ZHONGFU Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ZHONGFU Pharmaceutical Lisinopril Tablets Product Portfolio
6.2.5 ZHONGFU Pharmaceutical Recent Developments/Updates
6.3 Ningbo Menovo TianKang Pharmaceutical
6.3.1 Ningbo Menovo TianKang Pharmaceutical Corporation Information
6.3.2 Ningbo Menovo TianKang Pharmaceutical Description and Business Overview
6.3.3 Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Product Portfolio
6.3.5 Ningbo Menovo TianKang Pharmaceutical Recent Developments/Updates
6.4 Shanghai Great Wall Pharmaceutical
6.4.1 Shanghai Great Wall Pharmaceutical Corporation Information
6.4.2 Shanghai Great Wall Pharmaceutical Description and Business Overview
6.4.3 Shanghai Great Wall Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Great Wall Pharmaceutical Lisinopril Tablets Product Portfolio
6.4.5 Shanghai Great Wall Pharmaceutical Recent Developments/Updates
6.5 Sinopharm Shantou Jinshi Pharmaceutical
6.5.1 Sinopharm Shantou Jinshi Pharmaceutical Corporation Information
6.5.2 Sinopharm Shantou Jinshi Pharmaceutical Description and Business Overview
6.5.3 Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Product Portfolio
6.5.5 Sinopharm Shantou Jinshi Pharmaceutical Recent Developments/Updates
6.6 Jiangsu Huanghe Medical
6.6.1 Jiangsu Huanghe Medical Corporation Information
6.6.2 Jiangsu Huanghe Medical Description and Business Overview
6.6.3 Jiangsu Huanghe Medical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Jiangsu Huanghe Medical Lisinopril Tablets Product Portfolio
6.6.5 Jiangsu Huanghe Medical Recent Developments/Updates
6.7 Yichang HEC Changjiang Pharmaceutical
6.6.1 Yichang HEC Changjiang Pharmaceutical Corporation Information
6.6.2 Yichang HEC Changjiang Pharmaceutical Description and Business Overview
6.6.3 Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Product Portfolio
6.7.5 Yichang HEC Changjiang Pharmaceutical Recent Developments/Updates
6.8 Hebei Wansui Pharmaceutical
6.8.1 Hebei Wansui Pharmaceutical Corporation Information
6.8.2 Hebei Wansui Pharmaceutical Description and Business Overview
6.8.3 Hebei Wansui Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hebei Wansui Pharmaceutical Lisinopril Tablets Product Portfolio
6.8.5 Hebei Wansui Pharmaceutical Recent Developments/Updates
6.9 Jincheng Haisi Pharmaceutical
6.9.1 Jincheng Haisi Pharmaceutical Corporation Information
6.9.2 Jincheng Haisi Pharmaceutical Description and Business Overview
6.9.3 Jincheng Haisi Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jincheng Haisi Pharmaceutical Lisinopril Tablets Product Portfolio
6.9.5 Jincheng Haisi Pharmaceutical Recent Developments/Updates
6.10 Jiangsu Kanion Pharmaceutical
6.10.1 Jiangsu Kanion Pharmaceutical Corporation Information
6.10.2 Jiangsu Kanion Pharmaceutical Description and Business Overview
6.10.3 Jiangsu Kanion Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jiangsu Kanion Pharmaceutical Lisinopril Tablets Product Portfolio
6.10.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.11 Zhejiang Huahai Pharmaceutical
6.11.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.11.2 Zhejiang Huahai Pharmaceutical Lisinopril Tablets Description and Business Overview
6.11.3 Zhejiang Huahai Pharmaceutical Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang Huahai Pharmaceutical Lisinopril Tablets Product Portfolio
6.11.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.12 Facmed Pharmaceuticals
6.12.1 Facmed Pharmaceuticals Corporation Information
6.12.2 Facmed Pharmaceuticals Lisinopril Tablets Description and Business Overview
6.12.3 Facmed Pharmaceuticals Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Facmed Pharmaceuticals Lisinopril Tablets Product Portfolio
6.12.5 Facmed Pharmaceuticals Recent Developments/Updates
6.13 Crescent
6.13.1 Crescent Corporation Information
6.13.2 Crescent Lisinopril Tablets Description and Business Overview
6.13.3 Crescent Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Crescent Lisinopril Tablets Product Portfolio
6.13.5 Crescent Recent Developments/Updates
6.14 Bristol
6.14.1 Bristol Corporation Information
6.14.2 Bristol Lisinopril Tablets Description and Business Overview
6.14.3 Bristol Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bristol Lisinopril Tablets Product Portfolio
6.14.5 Bristol Recent Developments/Updates
6.15 Actavis
6.15.1 Actavis Corporation Information
6.15.2 Actavis Lisinopril Tablets Description and Business Overview
6.15.3 Actavis Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Actavis Lisinopril Tablets Product Portfolio
6.15.5 Actavis Recent Developments/Updates
6.16 Healing Pharma
6.16.1 Healing Pharma Corporation Information
6.16.2 Healing Pharma Lisinopril Tablets Description and Business Overview
6.16.3 Healing Pharma Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Healing Pharma Lisinopril Tablets Product Portfolio
6.16.5 Healing Pharma Recent Developments/Updates
6.17 TAJ Pharma
6.17.1 TAJ Pharma Corporation Information
6.17.2 TAJ Pharma Lisinopril Tablets Description and Business Overview
6.17.3 TAJ Pharma Lisinopril Tablets Sales, Revenue and Gross Margin (2018-2023)
6.17.4 TAJ Pharma Lisinopril Tablets Product Portfolio
6.17.5 TAJ Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lisinopril Tablets Industry Chain Analysis
7.2 Lisinopril Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lisinopril Tablets Production Mode & Process
7.4 Lisinopril Tablets Sales and Marketing
7.4.1 Lisinopril Tablets Sales Channels
7.4.2 Lisinopril Tablets Distributors
7.5 Lisinopril Tablets Customers
8 Lisinopril Tablets Market Dynamics
8.1 Lisinopril Tablets Industry Trends
8.2 Lisinopril Tablets Market Drivers
8.3 Lisinopril Tablets Market Challenges
8.4 Lisinopril Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Lisinopril Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Lisinopril Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Lisinopril Tablets Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Lisinopril Tablets Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Lisinopril Tablets Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Lisinopril Tablets Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Lisinopril Tablets Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Lisinopril Tablets Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Lisinopril Tablets, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Lisinopril Tablets, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Lisinopril Tablets, Product Type & Application
    Table 12. Global Key Manufacturers of Lisinopril Tablets, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Lisinopril Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisinopril Tablets as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Lisinopril Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Lisinopril Tablets Sales by Region (2018-2023) & (K Units)
    Table 18. Global Lisinopril Tablets Sales Market Share by Region (2018-2023)
    Table 19. Global Lisinopril Tablets Sales by Region (2024-2029) & (K Units)
    Table 20. Global Lisinopril Tablets Sales Market Share by Region (2024-2029)
    Table 21. Global Lisinopril Tablets Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Lisinopril Tablets Revenue Market Share by Region (2018-2023)
    Table 23. Global Lisinopril Tablets Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Lisinopril Tablets Revenue Market Share by Region (2024-2029)
    Table 25. North America Lisinopril Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Lisinopril Tablets Sales by Country (2018-2023) & (K Units)
    Table 27. North America Lisinopril Tablets Sales by Country (2024-2029) & (K Units)
    Table 28. North America Lisinopril Tablets Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Lisinopril Tablets Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Lisinopril Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Lisinopril Tablets Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Lisinopril Tablets Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Lisinopril Tablets Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Lisinopril Tablets Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Lisinopril Tablets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Lisinopril Tablets Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Lisinopril Tablets Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Lisinopril Tablets Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Lisinopril Tablets Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Lisinopril Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Lisinopril Tablets Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Lisinopril Tablets Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Lisinopril Tablets Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Lisinopril Tablets Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Lisinopril Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Lisinopril Tablets Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Lisinopril Tablets Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Lisinopril Tablets Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Lisinopril Tablets Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Lisinopril Tablets Sales (K Units) by Type (2018-2023)
    Table 51. Global Lisinopril Tablets Sales (K Units) by Type (2024-2029)
    Table 52. Global Lisinopril Tablets Sales Market Share by Type (2018-2023)
    Table 53. Global Lisinopril Tablets Sales Market Share by Type (2024-2029)
    Table 54. Global Lisinopril Tablets Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Lisinopril Tablets Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Lisinopril Tablets Revenue Market Share by Type (2018-2023)
    Table 57. Global Lisinopril Tablets Revenue Market Share by Type (2024-2029)
    Table 58. Global Lisinopril Tablets Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Lisinopril Tablets Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Lisinopril Tablets Sales (K Units) by Application (2018-2023)
    Table 61. Global Lisinopril Tablets Sales (K Units) by Application (2024-2029)
    Table 62. Global Lisinopril Tablets Sales Market Share by Application (2018-2023)
    Table 63. Global Lisinopril Tablets Sales Market Share by Application (2024-2029)
    Table 64. Global Lisinopril Tablets Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Lisinopril Tablets Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Lisinopril Tablets Revenue Market Share by Application (2018-2023)
    Table 67. Global Lisinopril Tablets Revenue Market Share by Application (2024-2029)
    Table 68. Global Lisinopril Tablets Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Lisinopril Tablets Price (US$/Unit) by Application (2024-2029)
    Table 70. Shanghai Sine WANXIANG Pharmaceuticals Corporation Information
    Table 71. Shanghai Sine WANXIANG Pharmaceuticals Description and Business Overview
    Table 72. Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Shanghai Sine WANXIANG Pharmaceuticals Lisinopril Tablets Product
    Table 74. Shanghai Sine WANXIANG Pharmaceuticals Recent Developments/Updates
    Table 75. ZHONGFU Pharmaceutical Corporation Information
    Table 76. ZHONGFU Pharmaceutical Description and Business Overview
    Table 77. ZHONGFU Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. ZHONGFU Pharmaceutical Lisinopril Tablets Product
    Table 79. ZHONGFU Pharmaceutical Recent Developments/Updates
    Table 80. Ningbo Menovo TianKang Pharmaceutical Corporation Information
    Table 81. Ningbo Menovo TianKang Pharmaceutical Description and Business Overview
    Table 82. Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Ningbo Menovo TianKang Pharmaceutical Lisinopril Tablets Product
    Table 84. Ningbo Menovo TianKang Pharmaceutical Recent Developments/Updates
    Table 85. Shanghai Great Wall Pharmaceutical Corporation Information
    Table 86. Shanghai Great Wall Pharmaceutical Description and Business Overview
    Table 87. Shanghai Great Wall Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Shanghai Great Wall Pharmaceutical Lisinopril Tablets Product
    Table 89. Shanghai Great Wall Pharmaceutical Recent Developments/Updates
    Table 90. Sinopharm Shantou Jinshi Pharmaceutical Corporation Information
    Table 91. Sinopharm Shantou Jinshi Pharmaceutical Description and Business Overview
    Table 92. Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Sinopharm Shantou Jinshi Pharmaceutical Lisinopril Tablets Product
    Table 94. Sinopharm Shantou Jinshi Pharmaceutical Recent Developments/Updates
    Table 95. Jiangsu Huanghe Medical Corporation Information
    Table 96. Jiangsu Huanghe Medical Description and Business Overview
    Table 97. Jiangsu Huanghe Medical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Jiangsu Huanghe Medical Lisinopril Tablets Product
    Table 99. Jiangsu Huanghe Medical Recent Developments/Updates
    Table 100. Yichang HEC Changjiang Pharmaceutical Corporation Information
    Table 101. Yichang HEC Changjiang Pharmaceutical Description and Business Overview
    Table 102. Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Yichang HEC Changjiang Pharmaceutical Lisinopril Tablets Product
    Table 104. Yichang HEC Changjiang Pharmaceutical Recent Developments/Updates
    Table 105. Hebei Wansui Pharmaceutical Corporation Information
    Table 106. Hebei Wansui Pharmaceutical Description and Business Overview
    Table 107. Hebei Wansui Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Hebei Wansui Pharmaceutical Lisinopril Tablets Product
    Table 109. Hebei Wansui Pharmaceutical Recent Developments/Updates
    Table 110. Jincheng Haisi Pharmaceutical Corporation Information
    Table 111. Jincheng Haisi Pharmaceutical Description and Business Overview
    Table 112. Jincheng Haisi Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Jincheng Haisi Pharmaceutical Lisinopril Tablets Product
    Table 114. Jincheng Haisi Pharmaceutical Recent Developments/Updates
    Table 115. Jiangsu Kanion Pharmaceutical Corporation Information
    Table 116. Jiangsu Kanion Pharmaceutical Description and Business Overview
    Table 117. Jiangsu Kanion Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Jiangsu Kanion Pharmaceutical Lisinopril Tablets Product
    Table 119. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
    Table 120. Zhejiang Huahai Pharmaceutical Corporation Information
    Table 121. Zhejiang Huahai Pharmaceutical Description and Business Overview
    Table 122. Zhejiang Huahai Pharmaceutical Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Zhejiang Huahai Pharmaceutical Lisinopril Tablets Product
    Table 124. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
    Table 125. Facmed Pharmaceuticals Corporation Information
    Table 126. Facmed Pharmaceuticals Description and Business Overview
    Table 127. Facmed Pharmaceuticals Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Facmed Pharmaceuticals Lisinopril Tablets Product
    Table 129. Facmed Pharmaceuticals Recent Developments/Updates
    Table 130. Crescent Corporation Information
    Table 131. Crescent Description and Business Overview
    Table 132. Crescent Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 133. Crescent Lisinopril Tablets Product
    Table 134. Crescent Recent Developments/Updates
    Table 135. Bristol Corporation Information
    Table 136. Bristol Description and Business Overview
    Table 137. Bristol Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 138. Bristol Lisinopril Tablets Product
    Table 139. Bristol Recent Developments/Updates
    Table 140. Actavis Corporation Information
    Table 141. Actavis Description and Business Overview
    Table 142. Actavis Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 143. Actavis Lisinopril Tablets Product
    Table 144. Actavis Recent Developments/Updates
    Table 145. Healing Pharma Corporation Information
    Table 146. Healing Pharma Description and Business Overview
    Table 147. Healing Pharma Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 148. Healing Pharma Lisinopril Tablets Product
    Table 149. Healing Pharma Recent Developments/Updates
    Table 150. TAJ Pharma Corporation Information
    Table 151. TAJ Pharma Description and Business Overview
    Table 152. TAJ Pharma Lisinopril Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 153. TAJ Pharma Lisinopril Tablets Product
    Table 154. TAJ Pharma Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Lisinopril Tablets Distributors List
    Table 158. Lisinopril Tablets Customers List
    Table 159. Lisinopril Tablets Market Trends
    Table 160. Lisinopril Tablets Market Drivers
    Table 161. Lisinopril Tablets Market Challenges
    Table 162. Lisinopril Tablets Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Lisinopril Tablets
    Figure 2. Global Lisinopril Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Lisinopril Tablets Market Share by Type in 2022 & 2029
    Figure 4. 5mg/Tablet Product Picture
    Figure 5. 10mg/Tablet Product Picture
    Figure 6. 20mg/Tablet Product Picture
    Figure 7. Global Lisinopril Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Lisinopril Tablets Market Share by Application in 2022 & 2029
    Figure 9. Hospital Pharmacy
    Figure 10. Retail Pharmacy
    Figure 11. Others
    Figure 12. Global Lisinopril Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Lisinopril Tablets Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Lisinopril Tablets Sales (2018-2029) & (K Units)
    Figure 15. Global Lisinopril Tablets Average Price (US$/Unit) & (2018-2029)
    Figure 16. Lisinopril Tablets Report Years Considered
    Figure 17. Lisinopril Tablets Sales Share by Manufacturers in 2022
    Figure 18. Global Lisinopril Tablets Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Lisinopril Tablets Players: Market Share by Revenue in 2022
    Figure 20. Lisinopril Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Lisinopril Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Lisinopril Tablets Sales Market Share by Country (2018-2029)
    Figure 23. North America Lisinopril Tablets Revenue Market Share by Country (2018-2029)
    Figure 24. United States Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Lisinopril Tablets Sales Market Share by Country (2018-2029)
    Figure 27. Europe Lisinopril Tablets Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Lisinopril Tablets Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Lisinopril Tablets Revenue Market Share by Region (2018-2029)
    Figure 35. China Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. China Taiwan Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Latin America Lisinopril Tablets Sales Market Share by Country (2018-2029)
    Figure 45. Latin America Lisinopril Tablets Revenue Market Share by Country (2018-2029)
    Figure 46. Mexico Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Brazil Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Argentina Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Lisinopril Tablets Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Lisinopril Tablets Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. UAE Lisinopril Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Lisinopril Tablets by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Lisinopril Tablets by Type (2018-2029)
    Figure 56. Global Lisinopril Tablets Price (US$/Unit) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Lisinopril Tablets by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Lisinopril Tablets by Application (2018-2029)
    Figure 59. Global Lisinopril Tablets Price (US$/Unit) by Application (2018-2029)
    Figure 60. Lisinopril Tablets Value Chain
    Figure 61. Lisinopril Tablets Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS